Impact of proton pump inhibitors on clinical outcomes in patients after acute myocardial infarction: a propensity score analysis from China Acute Myocardial Infarction (CAMI) registry

BACKGROUND: Proton pump inhibitors (PPIs) are recommended by the latest guidelines to reduce the risk of bleeding in acute myocardial infarction (AMI) patients treated with dual antiplatelet therapy (DAPT). However, previous pharmacodynamic and clinical studies have reported controversial results on...

Descripción completa

Detalles Bibliográficos
Autores principales: SHI, Wen-Ce, GAO, Si-De, YANG, Jin-Gang, FAN, Xiao-Xue, NI, Lin, SU, Shu-Hong, YU, Mei, YANG, Hong-Mei, YU, Meng-Yue, YANG, Yue-Jin, on behalf of China Acute Myocardial In-farction (CAMI) Registry study group
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Science Press 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7729183/
https://www.ncbi.nlm.nih.gov/pubmed/33343644
http://dx.doi.org/10.11909/j.issn.1671-5411.2020.11.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7729183/
https://www.ncbi.nlm.nih.gov/pubmed/33343644
http://dx.doi.org/10.11909/j.issn.1671-5411.2020.11.008

Ejemplares similares